Clinical Trial Update: Phenylalanine and Its Impact on Cognition [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining phenylalanine and its impact on cognition in phenylketonuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Phenylketonuria | Phase 4 | Status: COMPLETED